News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,988 Results
Type
Article (1927)
Company Profile (2)
Press Release (68059)
Section
Business (21473)
Career Advice (9)
Deals (4555)
Drug Development (8160)
FDA (1804)
Job Trends (800)
News (37030)
Policy (3561)
Tag
Academia (93)
Allergies (5)
Alliances (8143)
ALS (6)
Alzheimer's disease (123)
Antibody-drug conjugate (ADC) (13)
Approvals (1835)
Artificial intelligence (14)
Automation (1)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (22)
Biotechnology (5)
Bladder cancer (11)
Brain cancer (2)
Breast cancer (21)
Cancer (220)
Cardiovascular disease (5)
Career advice (9)
CAR-T (4)
Cell therapy (25)
Clinical research (7034)
Collaboration (94)
Compensation (9)
Complete response letters (2)
COVID-19 (185)
C-suite (16)
Cystic fibrosis (4)
Data (201)
Depression (1)
Diabetes (14)
Diagnostics (598)
Digital health (1)
Drug discovery (13)
Duchenne muscular dystrophy (12)
Earnings (7637)
Events (7006)
Executive appointments (49)
FDA (1954)
Featured Employer (1)
Fibrodysplasia Ossificans Progressiva (1)
Funding (60)
Gene editing (3)
Gene therapy (19)
GLP-1 (45)
Government (233)
Grass and pollen (1)
Guidances (4)
Healthcare (1076)
IgA nephropathy (4)
Immunology and inflammation (1)
Indications (3)
Infectious disease (192)
Inflammatory bowel disease (17)
Influenza (6)
Intellectual property (17)
IPO (1625)
Job creations (241)
Job search strategy (9)
Layoffs (6)
Legal (951)
Liver cancer (16)
Lung cancer (36)
Lymphoma (14)
Manufacturing (31)
MASH (7)
Medical device (1123)
Medtech (1124)
Mergers & acquisitions (3027)
Metabolic disorders (39)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (7)
Neuroscience (168)
NextGen: Class of 2025 (219)
Non-profit (61)
Northern California (138)
Obesity (16)
Opinion (1)
Ovarian cancer (10)
Pain (4)
Pancreatic cancer (8)
Parkinson's disease (15)
Partnered (2)
Patents (19)
Patient recruitment (8)
People (4967)
Pharmaceutical (3)
Phase I (1910)
Phase II (2949)
Phase III (2664)
Pipeline (125)
Postmarket research (241)
Preclinical (668)
Press Release (2)
Prostate cancer (8)
Radiopharmaceuticals (22)
Rare diseases (27)
Real estate (601)
Regulatory (2603)
Reports (6)
Research institute (92)
Schizophrenia (7)
Series A (15)
Series B (7)
Service/supplier (1)
Sickle cell disease (1)
Southern California (161)
Spinal muscular atrophy (4)
Startups (423)
Stomach cancer (1)
Supply chain (8)
United States (1325)
Vaccines (24)
Venture capitalists (2)
Weight loss (2)
Women's health (1)
Date
Today (13)
Last 7 days (69)
Last 30 days (219)
Last 365 days (2925)
2025 (889)
2024 (3254)
2023 (3814)
2022 (7016)
2021 (6374)
2020 (5877)
2019 (3867)
2018 (3010)
2017 (3560)
2016 (3172)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Alabama (1)
Arizona (8)
Asia (21397)
Australia (2434)
California (351)
Canada (225)
China (165)
Colorado (4)
Connecticut (14)
Delaware (4)
Europe (12474)
Florida (22)
Georgia (7)
Illinois (16)
India (11)
Indiana (4)
Japan (82)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (75)
Massachusetts (243)
Michigan (2)
Minnesota (27)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (201)
New York (148)
North Carolina (61)
Northern California (138)
Ohio (2)
Oregon (1)
Pennsylvania (54)
South America (106)
Southern California (161)
Tennessee (1)
Texas (28)
Utah (13)
Virginia (25)
Washington D.C. (2)
Washington State (17)
Wisconsin (6)
69,988 Results for "phoremost ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim
PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim.
June 3, 2024
·
2 min read
Genetown
PhoreMost Introduces GlueSEEKER Platform for Discovery of Molecular Glue Degraders
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced the introduction of GlueSEEKER™.
May 21, 2024
·
2 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Genetown
PhoreMost and ThinkCyte Collaborate to Advance AI-based Drug Discovery
PhoreMost Ltd. and ThinkCyte K.K. announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence.
December 13, 2022
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
April 28, 2025
·
3 min read
1 of 6,999
Next
